Milica Kontić

3.9k total citations
43 papers, 315 citations indexed

About

Milica Kontić is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Milica Kontić has authored 43 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 19 papers in Pulmonary and Respiratory Medicine and 11 papers in Cancer Research. Recurrent topics in Milica Kontić's work include Lung Cancer Treatments and Mutations (15 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Epigenetics and DNA Methylation (8 papers). Milica Kontić is often cited by papers focused on Lung Cancer Treatments and Mutations (15 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Epigenetics and DNA Methylation (8 papers). Milica Kontić collaborates with scholars based in Serbia, United States and Spain. Milica Kontić's co-authors include Ljudmila Stojanovich, Aleksandra Djoković, Jelena Stojšić, Dragomir Marisavljević, Heather H. Nelson, Dragana Jovanović, Simona Ognjanovic, Nataša Stanisavljević, Dragana J. Jovanović and Vesna Škodrić-Trifunović and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Respiratory Journal and Human Mutation.

In The Last Decade

Milica Kontić

35 papers receiving 312 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Milica Kontić Serbia 11 111 94 93 84 44 43 315
Eva Markert Germany 9 167 1.5× 82 0.9× 181 1.9× 129 1.5× 61 1.4× 20 405
J. Mazurka Canada 10 85 0.8× 167 1.8× 120 1.3× 36 0.4× 45 1.0× 15 488
Yuko Toyoda Japan 14 288 2.6× 93 1.0× 92 1.0× 62 0.7× 26 0.6× 36 457
L. Burke United States 8 117 1.1× 67 0.7× 44 0.5× 111 1.3× 24 0.5× 11 374
Jake Allred United States 8 57 0.5× 55 0.6× 258 2.8× 57 0.7× 49 1.1× 13 373
R. Mondéjar Spain 8 67 0.6× 48 0.5× 219 2.4× 38 0.5× 14 0.3× 23 380
Laura Yébenes Spain 11 93 0.8× 72 0.8× 134 1.4× 48 0.6× 75 1.7× 24 347
Eivind Smeland Norway 14 195 1.8× 98 1.0× 231 2.5× 37 0.4× 43 1.0× 22 441
Remi Sumiyoshi Japan 11 49 0.4× 96 1.0× 99 1.1× 140 1.7× 12 0.3× 50 359
Aurélie Vogt United States 6 72 0.6× 96 1.0× 94 1.0× 21 0.3× 62 1.4× 12 244

Countries citing papers authored by Milica Kontić

Since Specialization
Citations

This map shows the geographic impact of Milica Kontić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Milica Kontić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Milica Kontić more than expected).

Fields of papers citing papers by Milica Kontić

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Milica Kontić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Milica Kontić. The network helps show where Milica Kontić may publish in the future.

Co-authorship network of co-authors of Milica Kontić

This figure shows the co-authorship network connecting the top 25 collaborators of Milica Kontić. A scholar is included among the top collaborators of Milica Kontić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Milica Kontić. Milica Kontić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kontić, Milica, et al.. (2023). Brief Report: Predictive value of PD-L1 Expression in non–Small-Cell Lung Cancer - Should we Set the Bar Higher for Monotherapy?. Clinical Lung Cancer. 24(6). e214–e218. 4 indexed citations
3.
Kontić, Milica, et al.. (2021). Is hypermethylation of SOX1 gene an independent prognostic marker in surgically resected non-small cell lung cancer?. Journal of Cancer Research and Therapeutics. 18(6). 1692–1696. 5 indexed citations
4.
Kontić, Milica, et al.. (2018). Are the cutaneous manifestations in patients with primary antiphospholipid syndrome a marker for predicting lung manifestations?. PubMed. 36(1). 56–61. 7 indexed citations
5.
Kontić, Milica, et al.. (2018). P2.16-05 Hypermethylation of SOX1, RASSF1A, HOXA9, CDH13 and DAPK Genes Plays a Role in NSCLC Pathogenesis. Journal of Thoracic Oncology. 13(10). S832–S832. 1 indexed citations
6.
Jovanović, Dragana, et al.. (2018). Membrane PD-L1 expression and soluble PD-L1 plasma levels in idiopathic pulmonary fibrosis—a pilot study. Journal of Thoracic Disease. 10(12). 6660–6669. 41 indexed citations
7.
Jovanović, Dragana, et al.. (2017). Durable complete remission of poor performance status metastatic lung adenocarcinoma patient treated with second-line erlotinib: a case report. OncoTargets and Therapy. Volume 10. 4347–4354. 3 indexed citations
8.
Kontić, Milica, et al.. (2016). A preliminary study on the relationship between circulating tumor cells count and clinical features in patients with non-small cell lung cancer. Journal of Thoracic Disease. 8(6). 1029–1031. 11 indexed citations
9.
Ananiev, Julian, Maya Gulubova, Anastasiya Atanasova Chokoeva, et al.. (2015). Impact of HER2 codon 655 polymorphism and expression of HER2 and HER3 in non small cell lung cancer patients. Wiener Medizinische Wochenschrift. 165(15-16). 315–321. 1 indexed citations
10.
Stojšić, Jelena, et al.. (2014). Intestinal Type of Lung Adenocarcinoma in Younger Adults. Case Reports in Pulmonology. 2014. 1–4. 18 indexed citations
11.
Djoković, Aleksandra, Ljudmila Stojanovich, Milica Kontić, et al.. (2014). Association between cardiac manifestations and antiphospholipid antibody type and level in a cohort of Serbian patients with primary and secondary antiphospholipid syndrome.. PubMed. 16(3). 162–7. 25 indexed citations
12.
Stojanovich, Ljudmila, Milica Kontić, Aleksandra Djoković, et al.. (2013). Association between systemic non-criteria APS manifestations and antibody type and level: results from the Serbian national cohort study.. PubMed. 31(2). 234–42. 16 indexed citations
13.
Stojanovich, Ljudmila, Milica Kontić, Aleksandra Djoković, et al.. (2012). Pulmonary events in antiphospholipid syndrome: influence of antiphospholipid antibody type and levels. Scandinavian Journal of Rheumatology. 41(3). 223–226. 11 indexed citations
14.
Milanović, Milomir, et al.. (2012). Influenza Vaccination in Autoimmune Rheumatic Disease Patients. The Tohoku Journal of Experimental Medicine. 229(1). 29–34. 18 indexed citations
15.
Kontić, Milica, et al.. (2012). Could Spindle Cell Lung Carcinoma be Considered and Treated as Sarcoma, According to its Clinical Course, Morphology, Immunophenotype and Genetic Finding?. Pathology & Oncology Research. 19(1). 129–133. 5 indexed citations
16.
Kontić, Milica, Jelena Stojšić, Dragana J. Jovanović, et al.. (2011). Quantitative methylation profiles of multiple genes in patients with non-small cell lung cancer and its association with clinicopathological correlations. European Respiratory Journal. 38(Suppl 55). p1952–p1952. 1 indexed citations
17.
Stojšić, Jelena, et al.. (2011). Angiomatosis of the thoracic wall. Journal of Orthopaedic Science. 18(1). 186–189. 1 indexed citations
18.
19.
Stojšić, Jelena, et al.. (2010). Large Cell Lung Carcinoma with Unusual Imaging Feature, Immunophenotype and Genetic Finding. Pathology & Oncology Research. 17(1). 175–179. 7 indexed citations
20.
Kontić, Milica, et al.. (2006). New RB1 oncogenic mutations and intronic polymorphisms in Serbian retinoblastoma patients: genetic counseling implications. Journal of Human Genetics. 51(10). 909–913. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eva Markert Breakdown of academic impact, for papers by J. Mazurka Breakdown of academic impact, for papers by Yuko Toyoda Breakdown of academic impact, for papers by L. Burke Breakdown of academic impact, for papers by Jake Allred Breakdown of academic impact, for papers by R. Mondéjar Breakdown of academic impact, for papers by Laura Yébenes Breakdown of academic impact, for papers by Eivind Smeland Breakdown of academic impact, for papers by Remi Sumiyoshi Breakdown of academic impact, for papers by Aurélie Vogt
Rankless by CCL
2026